Invesco
FBIO icon

Invesco’s Fortress Biotech FBIO Stock Holding History

Invesco’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,731
Closed -$35K – 4076
2022
Q1 		$35K Buy
1,731
+56
+3% +$1.53K ﹤0.01% 3954
2021
Q4 		$63K Sell
1,675
-27
-2% -$1.2K ﹤0.01% 3955
2021
Q3 		$82K Buy
1,702
+415
+32% +$20.3K ﹤0.01% 3964
2021
Q2 		$69K Buy
1,287
+147
+13% +$8.87K ﹤0.01% 3931
2021
Q1 		$60K Buy
1,140
+230
+25% +$13K ﹤0.01% 3820
2020
Q4 		$43K Buy
+910
New +$39.4K ﹤0.01% 3749
2019
Q1 		– Sell
-930
Closed -$12K – 3738
2018
Q4 		$12K Buy
930
+60
+7% +$1K ﹤0.01% 3774
2018
Q3 		$21K Buy
870
+50
+6% +$1.6K ﹤0.01% 3846
2018
Q2 		$37K Buy
820
+41
+5% +$2.31K ﹤0.01% 3812
2018
Q1 		$53K Sell
779
-370
-32% -$23.4K ﹤0.01% 3679
2017
Q4 		$69K Buy
1,149
+118
+11% +$6.95K ﹤0.01% 3617
2017
Q3 		$68K Buy
1,031
+128
+14% +$8.63K ﹤0.01% 3620
2017
Q2 		$64K Buy
+903
New +$53.3K ﹤0.01% 3661
2015
Q2 		– Sell
-753
Closed -$43K – 4339
2015
Q1 		$43K Sell
753
-37,749
-98% -$1.57M ﹤0.01% 3910
2014
Q4 		$1.41M Buy
+38,502
New +$1.13M ﹤0.01% 2739
2014
Q1 		– Sell
-7
Closed – – 4136
2013
Q4 		$0 Buy
+7
New +$270 ﹤0.01% 4340

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Invesco's FBIO Position: Q2 2022 in Review

Invesco sold out of Fortress Biotech (FBIO) in Q2 2022, closing a stake of 1,731 shares — an estimated $35K sold.

Invesco first reported a position in FBIO in Q4 2013 and held it in 16 quarters. The position peaked at $1.41M in Q4 2014. 66 funds tracked by Wall St. Rank hold FBIO as of Q2 2022.

  • Invesco reported no remaining Fortress Biotech position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 1,731 Fortress Biotech shares in Q2 2022, an estimated $35K.
  • Invesco first reported a position in Fortress Biotech in Q4 2013 and held it in 16 quarters.
  • Invesco's Fortress Biotech position peaked at $1.41M in Q4 2014.
  • 66 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.